Related Experiment Video
Updated: Jun 9, 2026

07:14
A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
Levodopa and subthalamic deep brain stimulation responses are not congruent
Adam Zaidel1, Hagai Bergman, Ya'acov Ritov
1The Interdisciplinary Center for Neural Computation, The Hebrew University of Jerusalem, Israel. adam@alice.nc.huji.ac.il
Movement Disorders : Official Journal of the Movement Disorder Society
|September 9, 2010
Summary
Preoperative levodopa response does not predict subthalamic nucleus deep brain stimulation (STN DBS) efficacy in Parkinson's disease. This finding challenges the use of levodopa responsiveness as a key selection criterion for STN DBS surgery.
Area of Science:
- Neurology
- Neurosurgery
- Movement Disorders
Background:
- Subthalamic nucleus deep brain stimulation (STN DBS) is a common treatment for Parkinson's disease.
- Preoperative levodopa responsiveness is widely believed to predict STN DBS efficacy.
Purpose of the Study:
- To re-evaluate the predictive value of preoperative levodopa responsiveness on STN DBS outcomes.
- To investigate potential statistical artifacts in previous findings.
Main Methods:
- Analysis of data from 49 Parkinson's disease patients undergoing STN DBS.
- Reproducing previously published correlation analyses.
- Assessing correlations using baseline and fractional motor improvement scores.
- Performing data shuffling to test robustness of findings.
Main Results:
- Previously reported correlations between levodopa responsiveness and STN DBS efficacy were reproduced but also observed in randomly shuffled data.
- No significant correlation was found between preoperative levodopa responsiveness and STN DBS efficacy when using appropriate baselines.
- Postoperative motor improvement, particularly tremor, was not limited by preoperative levodopa response.
Conclusions:
- Preoperative levodopa responsiveness does not reliably predict or limit STN DBS outcomes in Parkinson's disease.
- Levodopa and STN DBS may have distinct therapeutic mechanisms.
- The use of substantial preoperative levodopa responsiveness as a selection criterion for STN DBS warrants re-examination.

